[1] |
LUO Lingling, CUI Pangen. Update of tumor necrosis factor inhibitor for the treatment of non-psoriatic skin diseases [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(11): 698
-700,704
. |
[2] |
ZHU Peiqiu, JIANG Wei. Clinical phenotype and genotype of porokeratosis[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(9): 564
-568
. |
[3] |
CHENG Qing, WANG Xiao-Hua, LYU Ping, YANG Bin. Update of galectins and skin diseases[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(8): 506
-509
. |
[4] |
QIAN Yuetong, MA Donglai. Kikuchi-Fujimoto disease[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(8): 510
-512
. |
[5] |
WU Qingzhi, SUN Yi, ZENG Tongxiang. Three patients with sportrichosis diagnosed by DNA sequencing[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(12): 718
-720
. |
[6] |
MI Xia, SUN Xiaoqiang, ZHANG Heyi. Assessment of HPV clearance of photodynamic therapy using 5-aminolaevulinic acid for cervical high risk HPV infection[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(10): 592
-694
. |
[7] |
FENG Yanyan, LIU Junling, PU Xiongming. . Prevalence of the patients with psoriasis combined with metabolic syndrome in Xinjiang. [J]. China Journal of Leprosy and Skin Diseases, 2016, 32(3): 153
-155
. |
[8] |
XIE Zhen, CHEN Yuanhan, WANG Youwei, LIU Yangying, WAN Huiying, ZHOU Min. Relationship between advanced oxidation protein products and lupus nephritis [J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 391
-393
. |
[9] |
GUO Kun, XIAO Shengxiang, GENG Songmei. Expression of Klf4 in the lesions of the patients with psoriasis or eczema[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 394
-396
. |
[10] |
ZENG Chenglong, FENG Ting, YAN Dan, WANG Shengchun. Comparison of SAT, Liquid culture and PCR in detection of ureaplasma urealyticum[J]. China Journal of Leprosy and Skin Diseases, 2016, 32(7): 397
-398
. |
|